MedPath

Multi-center Study to Examine Changes to the Environment Surrounding the Electrodes in the Cochlea and to Capture the Most Challenging Listening Environments Experienced by Persons with a Cochlear Implant

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: The impedance measurement task using the Mobile Research App (MRA)
Registration Number
NCT06173687
Lead Sponsor
Cochlear
Brief Summary

This early feasibility study aims to collect pilot data on impedance measurements in real-world environments and to collect real-world and difficult listening situations and the factors impacting this, reflecting situations the subjects encounter during their daily life outside of the clinic. Improving the monitoring of both aspects may lead to improvements in monitoring and personalising the fitting to optimise hearing outcomes for persons with a cochlear implant.

Detailed Description

This is a feasibility, prospective, multi-country, multi-centre, cross-sectional interventional clinical investigation in adults with a CE labelled cochlear implant.

No Randomisation nor blinding to avoid bias is applicable in this study since there is no comparator.

Subjects will attend two scheduled study visits over a two-month study period. At and in between study visits, subjects will undergo hearing assessments and safety monitoring. The subjects will perform daily impedance test tasks and complete a questionnaire in order to obtain the first primary endpoint, i.e. characterization of Daily Impedance Fluctuations.

Furthermore, the subjects will do EMA tasks to obtain the secondary objectives to capture daily-life, real-world listening environments and challenging listening environments.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Aged 18 years or older (no upper age limit).
  • Implanted with CIC4-based implant with a Contour Advance, Slim Straight or Slim Modiolar electrode array with at least 6 months experience.
  • Candidate is a fluent speaker in the language used to assess speech perception performance, as determined by the investigator.
  • Willing and able to provide written informed consent.
Exclusion Criteria
  • Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire (digital literacy check).
  • A failed ECE1 or ECE2 (i.e. flagged, open circuit or short circuit)
  • Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues.
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All participantsThe impedance measurement task using the Mobile Research App (MRA)-
Primary Outcome Measures
NameTimeMethod
Impedance Measurements8 Weeks

Variance in mean electrode impedance (measured in kohm, averaged across 22 electrode contacts) per day for 8 weeks.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Cochlear Macquarie

🇦🇺

Sydney, New South Wales, Australia

HEARnet

🇦🇺

Carlton, Victoria, Australia

ENT Department, Sint-Augutinus Antwerp

🇧🇪

Wilrijk, Antwerp, Belgium

Cochlear Bone Anchored Solutions AB (CBAS)

🇸🇪

Mölnlycke, Västergötland, Sweden

© Copyright 2025. All Rights Reserved by MedPath